Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma

Martin Hutchings; Annika Loft Jakobsen; Mads Hansen; Anne Kiil Berthelsen; Lena Specht

doi:10.1111/j.1600-0609.2006.00802.x

Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma

Afdeling for Klinisk Fysiologi og Nuklearmedicin DIA

107 Citationer (Scopus)

Abstract

Early-stage Hodgkin lymphoma (HL) has excellent survival rates but carries a high risk of late treatment-related adverse effects. Modern, individualised therapeutic strategies require an accurate determination of the extent of the disease. This study investigated the potential impact of 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computerised tomogrpahy (FDG-PET/CT) in the planning of involved field radiotherapy (IFRT).

Originalsprog	Engelsk
Tidsskrift	European Journal of Haematology
Vol/bind	78
Udgave nummer	3
Sider (fra-til)	206-12
Antal sider	7
ISSN	0902-4441
DOI	https://doi.org/10.1111/j.1600-0609.2006.00802.x
Status	Udgivet - 1 mar. 2007

Adgang til dokumentet

10.1111/j.1600-0609.2006.00802.x

Citationsformater

@article{b83b3468311847a790b87485ba267839,

title = "Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma",

abstract = "Early-stage Hodgkin lymphoma (HL) has excellent survival rates but carries a high risk of late treatment-related adverse effects. Modern, individualised therapeutic strategies require an accurate determination of the extent of the disease. This study investigated the potential impact of 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computerised tomogrpahy (FDG-PET/CT) in the planning of involved field radiotherapy (IFRT).",

author = "Martin Hutchings and Jakobsen, \{Annika Loft\} and Mads Hansen and Berthelsen, \{Anne Kiil\} and Lena Specht",

year = "2007",

month = mar,

day = "1",

doi = "10.1111/j.1600-0609.2006.00802.x",

language = "English",

volume = "78",

pages = "206--12",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma

AU - Hutchings, Martin

AU - Jakobsen, Annika Loft

AU - Hansen, Mads

AU - Berthelsen, Anne Kiil

AU - Specht, Lena

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Early-stage Hodgkin lymphoma (HL) has excellent survival rates but carries a high risk of late treatment-related adverse effects. Modern, individualised therapeutic strategies require an accurate determination of the extent of the disease. This study investigated the potential impact of 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computerised tomogrpahy (FDG-PET/CT) in the planning of involved field radiotherapy (IFRT).

AB - Early-stage Hodgkin lymphoma (HL) has excellent survival rates but carries a high risk of late treatment-related adverse effects. Modern, individualised therapeutic strategies require an accurate determination of the extent of the disease. This study investigated the potential impact of 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computerised tomogrpahy (FDG-PET/CT) in the planning of involved field radiotherapy (IFRT).

U2 - 10.1111/j.1600-0609.2006.00802.x

DO - 10.1111/j.1600-0609.2006.00802.x

M3 - Journal article

C2 - 17253974

SN - 0902-4441

VL - 78

SP - 206

EP - 212

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 3

ER -

Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater